• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIV的围产期传播及婴儿HIV感染的诊断:综述

Perinatal transmission of HIV and diagnosis of HIV infection in infants: a review.

作者信息

Nourse C B, Butler K M

机构信息

Department of Paediatrics, University College Dublin, Crumlin, Dublin.

出版信息

Ir J Med Sci. 1998 Jan-Mar;167(1):28-32. doi: 10.1007/BF02937550.

DOI:10.1007/BF02937550
PMID:9540296
Abstract

Paediatric HIV infection has become a major burden on families, communities and health services worldwide. The vast majority of children now acquire HIV as a result of mother to infant (vertical) transmission. Recent major advances have occurred following the greater understanding of the risk factors for perinatal transmission and the role of antiretroviral therapy in preventing transmission. Now that interruption of vertical transmission is possible, early identification of HIV-infected pregnant women is critical. As of June 1997, HIV infection has been diagnosed in 37 children under 15 yrs of age in the Republic of Ireland; 32 as a result of maternal to infant transmission. The exact timing of HIV transmission during pregnancy is unclear but it is estimated that 60-70 per cent of infants may be infected at the time of delivery with approximately 30 per cent infected earlier in gestation. Vertical transmission rates vary from 15-40 per cent in different global areas. Antenatal and perinatal zidovudine treatment can reduce this rate by 60-70 per cent. Risk factors for the vertical transmission of HIV-1 are multifactorial. These factors include maternal disease status, in particular maternal viral load, route of delivery, duration of membrane rupture, presence of obstetric complications and infant feeding practices. Definitive diagnosis of HIV infection in infancy has been difficult in the past. Direct viral detection methods now allow the reliable diagnosis of HIV infection in the first few months of life. The most effective intervention to reduce perinatal HIV infection will be the better identification of HIV positive pregnant women with the subsequent introduction of measures to interrupt vertical transmission of HIV.

摘要

小儿艾滋病毒感染已成为全球家庭、社区和卫生服务的一项主要负担。现在,绝大多数儿童感染艾滋病毒是母婴(垂直)传播所致。随着对围产期传播风险因素以及抗逆转录病毒疗法在预防传播中作用的进一步了解,最近取得了重大进展。既然可以阻断垂直传播,那么尽早识别感染艾滋病毒的孕妇至关重要。截至1997年6月,爱尔兰共和国已诊断出37名15岁以下儿童感染艾滋病毒;其中32名是母婴传播所致。孕期艾滋病毒传播的确切时间尚不清楚,但据估计,60%至70%的婴儿可能在分娩时感染,约30%在妊娠早期感染。全球不同地区的垂直传播率在15%至40%之间。产前和围产期使用齐多夫定治疗可使这一比率降低60%至70%。艾滋病毒-1垂直传播的风险因素是多方面的。这些因素包括母亲的疾病状况,尤其是母亲的病毒载量、分娩方式、胎膜破裂时间、产科并发症的存在以及婴儿喂养方式。过去,婴儿期艾滋病毒感染的确切诊断一直很困难。现在,直接病毒检测方法可在出生后的头几个月可靠地诊断艾滋病毒感染。降低围产期艾滋病毒感染的最有效干预措施将是更好地识别艾滋病毒呈阳性的孕妇,随后采取措施阻断艾滋病毒的垂直传播。

相似文献

1
Perinatal transmission of HIV and diagnosis of HIV infection in infants: a review.HIV的围产期传播及婴儿HIV感染的诊断:综述
Ir J Med Sci. 1998 Jan-Mar;167(1):28-32. doi: 10.1007/BF02937550.
2
Update: transmission of HIV-1 from mother to child.最新消息:人类免疫缺陷病毒1型(HIV-1)的母婴传播
Curr Opin Obstet Gynecol. 1997 Dec;9(6):343-8.
3
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.用于治疗符合抗逆转录病毒治疗条件的孕妇艾滋病毒感染的抗逆转录病毒疗法。
Cochrane Database Syst Rev. 2010 Mar 17(3):CD008440. doi: 10.1002/14651858.CD008440.
4
HIV infection and zidovudine use in childbearing women.育龄妇女中的艾滋病毒感染与齐多夫定的使用
Pediatrics. 2004 Dec;114(6):e707-12. doi: 10.1542/peds.2004-0414. Epub 2004 Nov 15.
5
Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.接受齐多夫定治疗的女性中人类免疫缺陷病毒1型围产期传播的危险因素。儿童艾滋病临床试验组研究185团队。
N Engl J Med. 1999 Aug 5;341(6):385-93. doi: 10.1056/NEJM199908053410601.
6
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.用于降低人类免疫缺陷病毒感染母婴传播风险的抗逆转录病毒药物。
Cochrane Database Syst Rev. 2007 Jan 24(1):CD003510. doi: 10.1002/14651858.CD003510.pub2.
7
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.用于降低艾滋病毒感染母婴传播风险的抗逆转录病毒药物。
Cochrane Database Syst Rev. 2011 Jul 6(7):CD003510. doi: 10.1002/14651858.CD003510.pub3.
8
Prevention of perinatal HIV transmission during pregnancy.孕期预防围产期HIV传播。
J Antimicrob Chemother. 2000 Nov;46(5):657-68. doi: 10.1093/jac/46.5.657.
9
U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.美国公共卫生服务部特别工作组关于在感染HIV-1的孕妇中使用抗逆转录病毒药物以促进孕产妇健康及采取干预措施减少美国围产期HIV-1传播的建议。
MMWR Recomm Rep. 2002 Nov 22;51(RR-18):1-38; quiz CE1-4.
10
Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1.拉米夫定与齐多夫定联合用药预防HIV-1母婴传播
JAMA. 2001 Apr 25;285(16):2083-93. doi: 10.1001/jama.285.16.2083.

本文引用的文献

1
Safety and pharmacokinetics of hyperimmune anti-human immunodeficiency virus (HIV) immunoglobulin administered to HIV-infected pregnant women and their newborns. Pediatric AIDS Clinical Trials Group Protocol 185 Pharmacokinetic Study Group.给予感染人类免疫缺陷病毒(HIV)的孕妇及其新生儿超免疫抗HIV免疫球蛋白的安全性和药代动力学。儿科艾滋病临床试验组方案185药代动力学研究组。
J Infect Dis. 1997 Feb;175(2):283-91. doi: 10.1093/infdis/175.2.283.
2
Diagnosis of perinatal human immunodeficiency virus infection by polymerase chain reaction and p24 antigen detection after immune complex dissociation in an urban community hospital.在一家城市社区医院,通过免疫复合物解离后聚合酶链反应和p24抗原检测诊断围产期人类免疫缺陷病毒感染
J Infect Dis. 1997 Jun;175(6):1333-6. doi: 10.1086/516464.
3
Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group.感染1型人类免疫缺陷病毒的婴儿的病毒载量与疾病进展。妇女与婴儿传播研究小组。
N Engl J Med. 1997 May 8;336(19):1337-42. doi: 10.1056/NEJM199705083361901.
4
Analysis of the maternal components of the AIDS clinical trial group 076 zidovudine regimen in the prevention of mother-to-infant transmission of human immunodeficiency virus type 1.艾滋病临床试验组076齐多夫定方案预防母婴传播1型人类免疫缺陷病毒的母体成分分析。
J Infect Dis. 1997 Apr;175(4):971-4. doi: 10.1086/514003.
5
Defining the time of fetal or perinatal acquisition of human immunodeficiency virus type 1 infection on the basis of age at first positive culture. Women and Infants Transmission Study (WITS).
J Infect Dis. 1997 Mar;175(3):712-5. doi: 10.1093/infdis/175.3.712.
6
Early detection of perinatal human immunodeficiency virus (HIV) type 1 infection using HIV RNA amplification and detection. New York City Perinatal HIV Transmission Collaborative Study.使用HIV RNA扩增和检测技术对围产期1型人类免疫缺陷病毒(HIV)感染进行早期检测。纽约市围产期HIV传播协作研究。
J Infect Dis. 1997 Mar;175(3):707-11. doi: 10.1093/infdis/175.3.707.
7
Maternal immunologic and virologic risk factors for infant human immunodeficiency virus type 1 infection: findings from the Women and Infants Transmission Study.婴儿感染1型人类免疫缺陷病毒的母体免疫和病毒学风险因素:妇女与婴儿传播研究的结果
J Infect Dis. 1997 Mar;175(3):567-75. doi: 10.1093/infdis/175.3.567.
8
Vertical HIV-1 transmission correlates with a high maternal viral load at delivery.
J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Jan 1;14(1):26-30. doi: 10.1097/00042560-199701010-00005.
9
Maternal virus load during pregnancy and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohort studies. SEROGEST Cohort Group.孕期母体病毒载量与1型人类免疫缺陷病毒母婴传播:法国围产期队列研究。SEROGEST队列研究组。
J Infect Dis. 1997 Jan;175(1):172-5. doi: 10.1093/infdis/175.1.172.
10
Vertical transmission of HIV-1: maternal immune status and obstetric factors. The European Collaborative Study.人类免疫缺陷病毒1型的垂直传播:母体免疫状态和产科因素。欧洲协作研究
AIDS. 1996 Dec;10(14):1675-81.